Top

BMC Surgery

Published in:

Open Access 01-12-2021 | Breast Augmentation | Case report

Breast contracture and skin sclerosis following 20 years of polyacrylamide hydrogel migration in a patient with familial vitiligo: a case report

Authors: Bin Wang, Jiaming Sun, Jing Tong

Published in: BMC Surgery | Issue 1/2021

Abstract

Background

Breast augmentation with polyacrylamide gel (PAAG) injection was approved in China in 1998 and later banned in 2006. The ban ensued numerous complaints from patients such as pain, induration, deformation, infection, displacement, and milk deposition associated with PAAG injection. To date, no study has investigated the long-term effect of PAAG migration on autoimmune diseases.

Case presentation

We report a rare case of a 49-year-old female patient with familial vitiligo who receiving PAAG injection for breast augmentation. The patient reported to have felt persistent movement of PAAG in her thoracoabdominal area for almost 20 years. Furthermore, the PAAG-induced chronic inflammation that aggravated vitiligo, which in turn promoted skin sclerosis. This damaged the breast contracture, increased chest tightness and induced mild breathing problems.

Conclusion

Here, we present a rare case in which a patient with a family history of vitiligo experienced long-term complications after receiving PAAG injection for breast augmentation. This case highlights the relationship between vitiligo, migration of PAAG and tissue hardening and skin contraction.

Level of evidence: Level V

Cheng NX, Wang YL, Wang JH, Zhang XM, Zhong H. Complications of breast augmentation with injected hydrophilic polyacrylamide gel. Aesthetic Plast Surg. 2002;26(5):375–82.CrossRef

Unukovych D, Khrapach V, Wickman M, Liljegren A, Mishalov V, Patlazhan G, Sandelin K. Polyacrylamide gel injections for breast augmentation: management of complications in 106 patients, a multicenter study. World J Surg. 2012;36(4):695–701.CrossRef

Christensen L, Breiting V. Management of postoperative complications of breast augmentation by injected polyacrylamide hydrogel. Aesthetic Plast Surg. 2006;30(1):132.CrossRef

Leung KM, Yeoh GP, Chan KW. Breast pathology in complications associated with polyacrylamide hydrogel (PAAG) mammoplasty. Hong Kong Med J. 2007;13(2):137–40.PubMed

State Food and Drug Administration: About prohibited the use of polyacrylamide hydrogel (injection) warning. http://www.sda.gov.cn/WS01/CL0493/93434.html. Accessed 10 May 2015.

Luo SK, Chen GP, Sun ZS, Cheng NX. Our strategy in complication management of augmentation mammaplasty with polyacrylamide hydrogel injection in 235 patients. J Plast Reconstr Aes. 2011;64:731–7.CrossRef

Xiaoling F, Yi C, Zhang Y, et al. Analysis of the complications induced by the polyacrylamide hydrogel injection. Plast Reconstr Surg. 2004;114:261–2.CrossRef

Qian B, Xiong L, Guo K, Wang R, Yang J, Wang Z, Tong J, Sun J. Comprehensive management of breast augmentation with polyacrylamide hydrogel injection based on 15 years of experience: a report on 325 cases. Ann Transl Med. 2020;8(7):475. https://doi.org/10.21037/atm.2020.03.68.PMID:32395519;PMCID:PMC7210124.CrossRefPubMedPubMedCentral

Qiao Q, Wang X, Sun J, Zhao R, Liu Z, Wang Y, Sun B, Yan Y, Qi K. Management for postoperative complications of breast augmentation by injected polyacrylamide hydrogel. Aesthetic Plast Surg. 2005;29(3):156–61.CrossRef

10.

Dahir AM, Thomsen SF. Comorbidities in vitiligo: comprehensive review. Int J Dermatol. 2018;57(10):1157–64. https://doi.org/10.1111/ijd.14055.CrossRefPubMed

11.

Sheth VM, Guo Y, Qureshi AA. Comorbidities associated with vitiligo: a ten-year retrospective study. Dermatology. 2013;227(4):311–5. https://doi.org/10.1159/000354607.CrossRefPubMed

12.

Chen YT, Chen YJ, Hwang CY, Lin MW, Chen TJ, Chen CC, Chu SY, Lee DD, Chang YT, Liu HN. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan. J Eur Acad Dermatol Venereol. 2015;29(7):1362–9. https://doi.org/10.1111/jdv.12870.CrossRefPubMed

13.

Amin SP, Marmur ES, Goldberg DJ. Complications from injectable polyacrylamide gel, a new nonbiodegradable soft tissue filler. Dermatol Surg. 2004;30(12 Pt 2):1507–9. https://doi.org/10.1111/j.1524-4725.2004.30551.x.CrossRefPubMed

Title: Breast contracture and skin sclerosis following 20 years of polyacrylamide hydrogel migration in a patient with familial vitiligo: a case report
Authors: Bin Wang
Jiaming Sun
Jing Tong
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Breast Augmentation
Breast Augmentation
Breast Augmentation
Vitiligo
Published in: BMC Surgery / Issue 1/2021
Electronic ISSN: 1471-2482
DOI: https://doi.org/10.1186/s12893-021-01097-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Breast contracture and skin sclerosis following 20 years of polyacrylamide hydrogel migration in a patient with familial vitiligo: a case report

Abstract

Background

Case presentation

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Case presentation

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

Learning curve of trans-sacral epiduroscopic laser decompression in herniated lumbar disc disease

Alimentary tract obstruction attributed to use of barbed suture for double tract reconstruction after robot-assisted proximal gastrectomy: a case report

Safety profile of preoperative administration of low-molecular-weight heparin on minimally invasive lung cancer surgery: a randomized controlled trial

Wound infection following implant removal of foot, ankle, lower leg or patella; a protocol for a multicenter randomized controlled trial investigating the (cost-)effectiveness of 2 g of prophylactic cefazolin compared to placebo (WIFI-2 trial)

Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis

Laparoscopic subtotal cholecystectomy after percutaneous transhepatic gallbladder drainage for grade II or III acute cholecystitis